SYNACT
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
SynAct Pharma operates in the pharmaceutical industry and focuses on the development of innovative treatments for inflammatory diseases. The company researches new therapies that can reduce inflammation and improve patient outcomes. The business is global with a primary presence in Europe and North America. SynAct Pharma was founded in 2012 and is headquartered in Lund, Sweden.
Read moreEPS (adj.)
Dividend %
Interim report Q2'26
Interim report Q3'26
Annual report '26
Don't miss out - create an account and get all the possible benefits